Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Risperidone 0.5mg, 1mg, 2mg. Description: Round, slightly convex, pink marbled orodispersible tablets. Presentation: 0.5mg-28, €8.80; 1mg-28, €18.93; 2mg-28, €37.92. Indications: Treatment of schizophrenia. Maintenance treatment in order to prevent relapse in chronic schizophrenia in patients having shown a response to initial treatment. Pharmacology: [...]
Boehringer Ingelheim wishes to announce that Combivent (ipratropium and salbutamol) Metered Aerosol will be discontinued in Ireland on June 30th 2008. Combivent Metered Aerosol is a CFC-containing inhaler, and in accordance with the Montreal Protocol concerning the phase-out of CFC-containing products, Boehringer Ingelheim has agreed to cease sales of this product by the end of [...]
Boehringer Ingelheim wishes to announce that Oramorph (morphine sulphate) UDVs10 mg/5 ml, Oramorph UDVs 30 mg/5 ml and Oramorph UDVs 100 mg/5 ml were discontinued on 31st March 2008. Oramorph oral solution (morphine sulphate 10 mg/5 ml) and Oramorph concentrated oral solution (morphine sulphate 20 mg/ml) are unaffected by this discontinuation and will remain available. [...]
Wyeth Pharmaceuticals would like to notify you of the discontinuation of Premique Cycle 10. Premique Cycle 10 has been discontinued with immediate effect. This product has not been available on the Irish Market since 2005. Wyeth Pharmaceuticals regrets any inconvenience this discontinuation may cause. Should you require any further information, please do not hesitate to [...]
Janssen-Cilag Ltd wishes to inform you that Retin-A 0.025% Cream has been discontinued due to commercial reasons. Retin-A 0.025% Cream was indicated for the treatment of acne vulgaris. Please note that Retin-A Gel 0.01% and 0.025% are still available. If you require further details, please do not hesitate to contact Janssen-Cilag Ltd at (01) 6202300.
Wyeth Pharmaceuticals would like to notify you of the discontinuation of Tri-Minulet. Tri-Minulet will be discontinued when current stock is exhausted at the end of 2008. Wyeth Pharmaceuticals regrets any inconvenience this discontinuation may cause. Should you require any further information, please do not hesitate to contact their medical information department at (01) 4493500.
AstraZeneca would like to inform you that Xylocaine 1% with adrenaline is being discontinued. It is anticipated that all stocks will be depleted by June 2008. Xylocaine 2% with adrenaline will remain on the market. Xylocaine 2% with adrenaline is indicated in adults and children over 12 years for the production of local anesthesia where [...]
Loading ...
